12 institutions reported holding $2.7M of BRIDGEBIO PHARMA INC (BBIO) in SEC 13F filings for 2026-06-30. Largest institutional holders: Assenagon Asset Management S.A. ($1.2M), Central Pacific Bank - Trust Division ($975,438), Westmount Partners, LLC ($232,229), HARBOR INVESTMENT ADVISORY, LLC ($136,671), GAMMA Investing LLC ($122,594). Source: SEC Form 13F.
| Rank | Institution | Value | Shares | Change |
|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | $1.2M | 15,620 | Trimmed |
| 2 | Central Pacific Bank - Trust Division | $975,438 | 243,767 | Added |
| 3 | Westmount Partners, LLC | $232,229 | 3,118 | Trimmed |
| 4 | HARBOR INVESTMENT ADVISORY, LLC | $136,671 | 1,835 | New |
| 5 | GAMMA Investing LLC | $122,594 | 1,646 | Added |
| 6 | CoreCap Advisors, LLC | $74,480 | 1,000 | Hold |
| 7 | Cedar Mountain Advisors, LLC | $11,098 | 149 | Hold |
| 8 | Dogwood Wealth Management LLC | $4,245 | 57 | Trimmed |
| 9 | MassMutual Private Wealth & Trust, FSB | $3,203 | 43 | Added |
| 10 | Retirement Wealth Solutions LLC | $1,639 | 22 | Trimmed |
| 11 | Versant Capital Management, Inc | $1,639 | 22 | Added |
| 12 | 3 FACTOR INDEXING, LLC | $75 | 1 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30